At a big hearing on drug patents, Congress got distracted by small tweaks – STAT
At a big hearing on drug patents, Congress got distracted by small tweaks STAT Despite their focus on drug prices, lawmakers seemed more eager to talk about peripheral tweaks to the patent system than about fundamental reforms.